Metabolic Associated Fatty Liver Disease (MAFLD) impacts approximately 25% of the global population. Between April 2023 and July 2023, 60 patients with MAFLD, along with 60 age, ethnicity, and sex-mat
Using an early-life antibiotic exposure model in BALB/c mice, we characterized the impact of prenatal and/or postnatal antibiotic exposures on the development of MAFLD in offspring through maternal ad
Background: Quantitative measurements of liver fat contents (LFCs) by magnetic resonance imaging derived-proton density fat fraction (MRI-PDFF) are accurate but limited by availability, convenience, a